Brian C. Stephenson - Feb 16, 2022 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Title: Secretary, Treasurer and Chief Financial Officer
Signature
/s/ Yi Ching Yau, Attorney-in-Fact
Stock symbol
BBIO
Transactions as of
Feb 16, 2022
Transactions value $
-$9,017
Form type
4
Date filed
2/18/2022, 03:35 PM
Previous filing
Dec 7, 2021
Next filing
Mar 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Options Exercise +2.49K +0.82% 307K Feb 16, 2022 Direct F1, F2
transaction BBIO Common Stock Tax liability -$9.02K -1.02K -0.33% $8.84 306K Feb 16, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Restricted Stock Units Options Exercise $0 -1.71K -10% $0.00 15.4K Feb 16, 2022 Common Stock 1.71K Direct F1, F4
transaction BBIO Restricted Stock Units Options Exercise $0 -778 -7.69% $0.00 9.34K Feb 16, 2022 Common Stock 778 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Includes 505 shares of the Issuer's Common Stock acquired by the Reporting Person on February 15, 2022 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
F3 Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 2,487 shares of Common Stock underlying the Reporting Person's RSUs.
F4 The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.
F5 The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.

Remarks:

Title: Secretary, Treasurer and Chief Financial Officer